Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis.
EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β -1a.
A case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion.
Cardiovascular Dysfunction in Multiple Sclerosis.
Adherence Associated with Oral Medications in the Treatment of Spasticity.
Microglia-blood vessel interactions: a double-edged sword in brain pathologies.
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Importance of Apolipoprotein A-I in Multiple Sclerosis.
Alterations in tight junction protein and IgG permeability accompany leukocyte extravasation across the choroid plexus during neuroinflammation.
In vivo imaging of human neuroinflammation.
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
In their own words: coping processes among women aging with multiple sclerosis.
Neuromyelitis optica (NMO IgG+) and genetic susceptibility, potential ethnic influences.
Neurological disorders and celiac disease.
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis.
Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
Cortical plasticity predicts recovery from relapse in multiple sclerosis.
SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.

Pages